- Stocks Telegraph Morning
- Posts
- Nov - 01 - NH - Morning Newsletter (with survey at top and bottom)
Nov - 01 - NH - Morning Newsletter (with survey at top and bottom)
4 Stocks Ready to Conquer Today's Market
The Newsheater daily morning newsletter is powered by Stocks Telegraph
Help us improve newsletter by taking
Good Morning!
As Wall Street prepared for the Federal Reserve's latest policy decision on interest rates, stock futures saw a slight dip on Wednesday, marking the end of a challenging month. Futures linked to the Dow Jones Industrial Average registered a 0.3% decrease, shedding 113 points, while S&P 500 futures and Nasdaq 100 futures each experienced a 0.4% decline. The Fed's decision is scheduled for release at 2 p.m. ET, followed by a news conference featuring Chair Jerome Powell at 2:30 p.m. ET.The Dow and the S&P 500 wrapped up the month with losses of 1.4% and 2.2%, respectively, marking their first three-month losing streak since March 2020. Simultaneously, the Nasdaq Composite recorded a 2.8% decline in October.Despite November's historical track record as a strong month for markets, investors remain vigilant regarding the recent surge in bond yields. Earlier this month, the benchmark 10-year U.S. Treasury yield surpassed the significant 5% milestone for the first time since 2007, prompting concerns about the potential consequences of enduring higher interest rates.
Free Report: Three of the Top NASDAQ Stocks to Buy Under $10
These stocks are flying well under the radar. But that may not be the case for long. The market may simply be overlooking a red-hot opportunity -- as they're doing with these three stocks.
Sponsored
Today Top Movers
SatixFy Communications Ltd. (SATX) stock soared 36.82% to $0.5199 in the pre-market trading after announcing completion of strategic $60 million transaction with MDA.
CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading up 16.23% at $45.25 at the time of writing following the completion of FDA advisory committee meeting for Exagamglogene Autotemcel (exa-cel) for severe sickle cell disease.
Bruush Oral Care Inc. (BRSH) grew over 20.55% at $0.2845 in pre-market trading today. The company recently announced pricing of $5.0 million private placement.
Sientra Inc (SIEN), a Medical Devices company, rose about 5.47% at $0.67 in pre-market trading Wednesday following the filing of 8-K form with the SEC.
A North American Lithium Corporation Still On the Rise
North American Lithium Corporation's Zeus Project found a reserve projected to be the 4th largest in the world for this sought after resource.
Sponsored
Top Upgrades & Downgrades
Barclays turned bullish on General Motors Company (GM), upgrading the stock to Overweight and assigning a $37 price target, representing potential upside of 29.28% from Wednesday's close.
Ford Motor Co. (F) has won the favor of Barclays' equity research team. The firm upgraded the shares from Equal-Weight to Overweight and moved their price target to $14, suggesting 40.7% additional upside for the stock.
Progressive Corp. (PGR) received an upgrade from analysts at Morgan Stanley, who also set their one-year price target on the stock to $160. They changed their rating on PGR to Equal-Weight from Underweight in a recently issued research note.
Earlier Wednesday Deutsche Bank reduced its rating on Paycom Software Inc (PAYC) stock to Hold from Buy and assigned the price target to $175.
Goldman Sachs analysts reduced their investment ratings, saying in research reports covered by the media that its rating for ZoomInfo Technologies Inc. (ZI) has been changed to Neutral from Buy and the new price target is set at $17.
Analysts at BofA downgraded Xponential Fitness Inc (XPOF)'s stock to Neutral from Buy Wednesday.
The New Billion-Dollar Monster
Can a beverage turn into billions? When you have the right team, it's possible.
The CEO that's already had a 350x Monster success in the beverage industry is about to take another swing with the perfect pitch at the perfect time.
With a huge 77% market share in his crosshairs, this founder has carved a lucrative niche in an $86B market.
Sponsored
Latest Insider Activity
Seres Therapeutics Inc (MCRB) CEO and President Shaff Eric D. announced the sale of shares taking place on Oct 30 at $1.35 for some 8,552 shares. The total came to more than $11545.0.
Flex Ltd (FLEX) Director McSweeney Erin sold on Oct 31 a total 9,500 shares at $25.64 on average. The insider’s sale generated proceeds of almost $0.24 million.
TransUnion (TRU) Director Zukauckas Linda declared the purchase of shares taking place on Oct 30 at $43.62 for some 2,350 shares. The transaction amount was around $0.1 million.
Citizens Financial Group Inc (CFG) Director Lillis Terrance bought on Oct 27 a total 1,000 shares at $22.86 on average. The purchase cost the insider an estimated $22,865.
Sell every Stock except ONE
Markets are down...
But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE.
He lives financially free trading this One Stock Once per month...
Sponsored
Important Earnings
Top US earnings releases scheduled for today include Qualcomm, Inc. (NASDAQ:QCOM). It will announce its Sep 2023 financial results. The company is expected to report earnings of $1.8 per share from revenues of $8.03B in the three-month period.
Analysts expect Mondelez International Inc. (NASDAQ:MDLZ) to report a net income (adjusted) of $0.74 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Sep 2023 is predicted to come in at $8.34B.
PayPal Holdings Inc (PYPL), due to announce earnings after the market closes today, is expected to report earnings of $1.16 per share from revenues of $6.96B recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Wouldn’t it be great to have a personalized solution for your investing needs? We’re adding new sections to the morning newsletter with big implications. All you have to do is share your thought about the current newsletter. If you do that, we’ll do our best to take your feedback and make it a better experience for you.
We are asking for 1 minute of your time to answer 4 questions about your experience with our newsletter. We hope to use this information to create solutions that address exactly what you need!
Thank you for your continued support.
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.